- Home
- IRON vs TRMD Comparison
IRON vs TRMD Comparison
Compare IRON & TRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- TRMD
- Stock Information
- Founded
- IRON 2017
- TRMD 1889
- Country
- IRON United States
- TRMD United Kingdom
- Employees
- IRON N/A
- TRMD N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- TRMD Marine Transportation
- Sector
- IRON Health Care
- TRMD Consumer Discretionary
- Exchange
- IRON Nasdaq
- TRMD Nasdaq
- Market Cap
- IRON 2.1B
- TRMD 1.8B
- IPO Year
- IRON N/A
- TRMD N/A
- Fundamental
- Price
- IRON $59.76
- TRMD $18.40
- Analyst Decision
- IRON Strong Buy
- TRMD Buy
- Analyst Count
- IRON 12
- TRMD 1
- Target Price
- IRON $92.08
- TRMD $23.00
- AVG Volume (30 Days)
- IRON 330.3K
- TRMD 611.0K
- Earning Date
- IRON 08-11-2025
- TRMD 08-14-2025
- Dividend Yield
- IRON N/A
- TRMD 21.77%
- EPS Growth
- IRON N/A
- TRMD N/A
- EPS
- IRON N/A
- TRMD 4.74
- Revenue
- IRON N/A
- TRMD $1,444,200,000.00
- Revenue This Year
- IRON N/A
- TRMD N/A
- Revenue Next Year
- IRON N/A
- TRMD N/A
- P/E Ratio
- IRON N/A
- TRMD $3.88
- Revenue Growth
- IRON N/A
- TRMD N/A
- 52 Week Low
- IRON $30.82
- TRMD $13.60
- 52 Week High
- IRON $68.73
- TRMD $39.04
- Technical
- Relative Strength Index (RSI)
- IRON 61.73
- TRMD 52.65
- Support Level
- IRON $58.63
- TRMD $18.51
- Resistance Level
- IRON $61.59
- TRMD $19.70
- Average True Range (ATR)
- IRON 2.15
- TRMD 0.41
- MACD
- IRON -0.14
- TRMD 0.08
- Stochastic Oscillator
- IRON 64.07
- TRMD 45.24
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About TRMD TORM plc
TORM PLC operates as a shipping company. The company owns and operates product tankers. It is engaged in the transportation of refined oil products The company transports clean petroleum products including gasoline, jet fuel, naphtha, and diesel oil, as well as other clean products. Its segments include the Tanker segment, and Marine Engineering segment. The company derives maximum revenue from Tanker segment.